Anatol Kreitzer serves as Executive at MapLight Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Anatol Kreitzer has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 24,455 shares valued at $0.
Anatol Kreitzer currently holds 24,455 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anatol Kreitzer has been a net neutral trader of MPLT stock. They have purchased $0 and sold $0 worth of shares.
Anatol Kreitzer's most recent insider trade was on Feb 5, 2026, when they sold 24,455 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2025 | MPLT | $0 | Award | 35,953 | $N/A | Discretionary |